Effects of selective cyclooxygenase-2 inhibitor on invasion of human hepatocelluar carcinoma cells
Zheng-Dong Fang,Jian-Sheng Li,Xiu-Cai Xu
DOI: https://doi.org/10.3969/j.issn.1009-3079.2006.03.009
2006-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the effects of Nimesuli, a selective cyclooxygenase inhibitor, on the invasion of human hepatocelluar carcinoma cell line SMMC-7721 and its mechanism. METHODS: Human hepatocelluar carcinoma cell line SMMC-7721 was divided into control (C) and Nimesuli (N) group. The cells in group N were treated with Nimesuli (25, 50, 100, 200, 400 μmol/L) and those in group C were treated with dimethylsulfoxide (DMSO). MTT reduction assay was used to evaluate the inhibitory rate, and Transwell chamber assay was performed to determine the effect of Nimesuli on the invasion of SMMC-7721 cells. The expression of matrix metalloproteinase (MMP) mRNA and enzymatic activity of SMMC-7721 cells were detected by reverse transcription polymerase chain reaction (RT-PCR) and gelatin zymography, respectively. RESULTS: Nimesuli inhibited the proliferation of SMMC-7721 cells in a time- and concentration-dependent manner. In comparison with those in the group C, the expression of MMP mRNA and enzymatic activity in group N were obviously lower after 25, 50, 100, 200, and 400 umol/L Nimesuli treatment (MMP2 mRNA: 0.968, 0.545, 0.330, 0.158, 0.083 vs 1.063, P <0.05 or P <0.01; MMP-9 mRNA: 1.005, 0.758, 0.465, 0.208, 0.103 vs 1.075, P <0.01 except the result of 25 μmol/L Nimesuli treatment). The invasion of SMMC-7721 cells was significantly inhibited in group N (P <0.05), and the inhibitory rates of the cells' penetrating polycarbonates were 7.8%, 28.0%, 35.6%, 53.6%, 61.4% for 25, 50, 100, 200, and 400 μmol/L, respectively. CONCLUSION: The selective cyclooxygenase inhibitor, Nimesuli, can inhibit the growth and invasion of SMMC-7721 cells and the possible mechanism may be involved in the down-regulation of MMP level.